ADPT icon

Adaptive Biotechnologies

209 hedge funds and large institutions have $1.08B invested in Adaptive Biotechnologies in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 88 increasing their positions, 58 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

5% less funds holding

Funds holding: 221209 (-12)

25% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 40

38% less capital invested

Capital invested by funds: $1.74B → $1.08B (-$657M)

Holders
209
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.62M
Puts
$417K
Net Calls
Net Calls Change

Top Sellers

1 -$16.5M
2 -$13.9M
3 -$10.9M
4
Ameriprise
Ameriprise
Minnesota
-$9M
5
TM
Tiger Management
New York
-$8.18M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$243M
2
$98.6M
3
$93.7M
4
$93.6M
5
$73M
6
$68.6M
7
$37.4M
8
$36.1M
9
$28.6M
10
$25.2M
11
$18.9M
12
$16.4M
13
$11.3M
14
$10.8M
15
$10.8M
16
$9.83M
17
$9.72M
18
$9.28M
19
$9.11M
20
$8.85M
21
$8.18M
22
$8.09M
23
$6.82M
24
$5.56M
25
$5.32M